Abituzumab
Adecatumumab[6]
Afutuzumab[9]
Alacizumab pegol[10]
Amatuximab[14]
Anetumab ravtansine[3]
Ascrinvacumab
Atezolizumab[20]
Avelumab[8]
Bavituximab[2]
Bevacizumab[12]
Brentuximab vedotin[33]
Brontictuzumab[23]
Cantuzumab mertansine
Cantuzumab ravtansine[30]
Catumaxomab[22]
cBR96-doxorubicin immunoconjugate
Cetuximab
Citatuzumab bogatox[9]
Cixutumumab
Clivatuzumab tetraxetan[40]
Codrituzumab[3]
Coltuximab ravtansine
Conatumumab[9]
Dacetuzumab[10]
Dalotuzumab[42]
Daratumumab
Demcizumab[44]
Denintuzumab mafodotin
Denosumab[45]
Depatuxizumab mafodotin[32]
Derlotuximab biotin[46]
Dinutuximab[47]
Drozitumab[50]
Duligotumab[51]
Durvalumab[53]
Dusigitumab[54]
Ecromeximab[17]
Elgemtumab[20]
Elotuzumab
Emactuzumab[23]
Emibetuzumab[57]
Enavatuzumab[58]
Enfortumab vedotin[59]
Enoblituzumab[61]
Ensituximab[63]
Epratuzumab
Ertumaxomab[22]
Etaracizumab
Farletuzumab
FBTA05[71][72]
Ficlatuzumab[76]
Figitumumab
Flanvotumab[77]
Fresolimumab
Futuximab[51]
Galiximab
Ganitumab[82]
Gemtuzumab ozogamicin
Girentuximab
Glembatumumab vedotin[85][86]
Icrucumab[88]
IMAB362
Imalumab[23]
Imgatuzumab[51]
Indatuximab ravtansine[30]
Indusatumab vedotin[20]
Inebilizumab
Intetumumab[89][90][91]
Ipilimumab[45]
Iratumumab[45]
Isatuximab[92]
Labetuzumab[55]
Lexatumumab[2]
Lifastuzumab vedotin
Lintuzumab
Lirilumab
Lirilumab
Lorvotuzumab mertansine
Lucatumumab[10]
Lumiliximab[6]
Lumretuzumab[23]
MABp1
Mapatumumab[22]
Margetuximab
Matuzumab[19]
Milatuzumab[10]
Mirvetuximab soravtansine[100]
Mogamulizumab
Narnatumab[104]
Necitumumab[105]
Nesvacumab
Nimotuzumab[45][108]
Nivolumab[109]
Obinutuzumab
Ocaratuzumab[111]
Ofatumumab[22]
Olaratumab
Onartuzumab[112]
Ontuxizumab[113]
Oportuzumab monatox[105]
Otlertuzumab[115]
Pamrevlumab[8]
Panitumumab[68]
Pankomab
Parsatuzumab[51]
Pasotuxizumab[23]
Patritumab[37]
Pembrolizumab[119]
Pertuzumab
Pidilizumab[120]
Pinatuzumab vedotin
Polatuzumab vedotin[26][122]
Pritumumab
Radretumab
Ramucirumab
Rilotumumab[126]
Rituximab
Robatumumab
Sacituzumab govitecan[130]
Samalizumab
Seribantumab[26]
SGN-CD19A
SGN-CD33A
Sibrotuzumab
Siltuximab
Sofituzumab vedotin[136]
Tabalumab[138]
Tacatuzumab tetraxetan
Tarextumab[139]
Tarextumab[139]
Teprotumumab[140]
Tetulomab
Ticilimumab (= tremelimumab)
Tigatuzumab[10]
TNX-650
Tovetumab[143]
Trastuzumab
Trastuzumab emtansine
TRBS07
Tremelimumab
Tucotuzumab celmoleukin[45][108]
Ublituximab[21]
Ulocuplumab[147]
Urelumab[148]
Utomilumab[32]
Vandortuzumab vedotin[20]
Vantictumab[149]
Vanucizumab
Varlilumab[150]
Veltuzumab[10]
Vesencumab[21]
Volociximab
Vorsetuzumab mafodotin[151]
Votumumab
Zalutumumab[22]
Zatuximab[51]